An oncology roundtable is a physician-focused forum where oncologists, subspecialists and other oncology professionals come together to discuss clinical questions, complex cases, treatment developments, and emerging trial opportunities. Unlike a formal tumor board, which generally follows a structured multidisciplinary case-review process, a roundtable can offer a more flexible setting for peer discussion and collaboration across practices or institutions.
oncology roundtable can support knowledge exchange, strengthen professional relationships, and create opportunities for regional oncology collaboration while keeping the treating physician involved in the patient’s care.
What Is an Oncology Roundtable?
An oncology roundtable can function as a physician case conference, educational discussion, or forum for ongoing peer collaboration, depending on how it is structured. Physicians may come together around a specific cancer type, treatment development, clinical question, or physician-submitted case.
The focus is usually practical. Physicians may discuss challenging cases, new evidence, treatment approaches, or whether a clinical trial could be relevant. These conversations can connect community oncologists with academic specialists, regional experts, and clinical investigators.
A roundtable is not intended to replace a physician’s clinical judgment. Instead, it creates another setting for physicians to exchange perspectives, ask questions, and stay informed as oncology continues to change.
What Happens During an Oncology Roundtable?
A subspecialist typically goes through clinical updates in SOC and best-in-class clinical trials for the highlighted patient type. This is followed by a cross-practice case discussion with all attendees.
The discussion can help physicians consider questions from more than one clinical perspective. It does not automatically establish a treatment recommendation or second opinion. Those decisions remain with the treating physician and appropriate care team.
Who Attends an Oncology Roundtable?
Participants depend on the purpose and structure of the session. A physician-led oncology roundtable may include community oncologists, academic oncologists, disease-specific subspecialists, regional key opinion leaders, and clinical investigators.
Bringing these perspectives together can support an academic-community oncology partnership based on ongoing communication rather than one-time referrals. Other oncology professionals may participate when their expertise is relevant to the topic or cases being discussed.
How Is an Oncology Roundtable Different From a Tumor Board?
An oncology roundtable and a tumor board can both involve multidisciplinary case discussion, but they do not necessarily serve the same purpose.
A tumor board is generally a structured treatment-planning process in which cancer specialists meet to review and discuss new or complex cases. Participants may include medical oncologists, radiation oncologists, surgeons, pathologists, radiologists, genetics experts, nurses, and other specialists involved in cancer care.
An oncology roundtable may have a broader and more flexible purpose. It can connect physicians across practices or institutions and combine case discussion with education, peer consultation, treatment updates, and discussion of evolving trial opportunities.
The distinction is not universal. Some roundtables may include detailed case reviews, while some tumor boards may include educational discussion. What matters is the structure, participants, purpose, and clinical responsibilities of the specific meeting.
In general, a tumor board is organized around multidisciplinary case review, while an oncology roundtable may provide a broader forum for physician-to-physician exchange.
Why Does Regional Oncology Collaboration Matter?
Cancer care is becoming more specialized. Treatment decisions may involve several oncology disciplines, molecular testing, and disease-specific expertise. Clinical trials and new treatment options can add another layer of complexity.
Local practices may not have every subspecialty available within their own practice, while academic physicians can benefit from stronger connections with community oncologists.
Regional oncology collaboration can help connect these areas of expertise. A physician can discuss a complex question with another specialist without necessarily transferring the patient’s ongoing care.
This approach may support communication between physicians before a formal consultation. Repeated interactions can make it easier to identify relevant expertise when additional input may be useful.
Are Oncology Roundtables Useful for Common Cases?
Yes. An oncology roundtable does not have to focus only on rare diseases or unusual cases.
Complexity can arise even when a diagnosis is common. Physicians may have questions about treatment sequencing, biomarker results, treatment response, adverse effects, new evidence, or clinical trial options. A case that appears routine may still involve a decision where peer input is useful.
For example, a physician may want to discuss how colleagues are approaching a particular treatment question or whether new evidence could affect the way a case is evaluated. A discussion does not determine the patient’s care automatically, but it can give the treating physician additional perspectives to consider.
The purpose is not to bring every case into a multidisciplinary review process. It is to create a setting for questions that may benefit from additional perspectives.
How Do Virtual and Regional Oncology Roundtables Work?
Virtual roundtables allow physicians from different practices or institutions to participate without traveling to the same location. Depending on the format, physicians may submit cases in advance, join a moderated discussion, or participate in a session focused on a specific disease or treatment topic.
Virtual and regional formats can make it easier for physicians from different practices to participate in the same discussion. Regular interaction may help physicians build relationships, understand one another’s expertise, and create a foundation for future collaboration.
The technology, meeting frequency, and participant structure can vary by organization.
How Can Roundtables Support Physician Collaboration?
The value of an oncology roundtable may extend beyond the meeting itself. Regular interaction helps physicians become familiar with one another’s specialties and areas of experience.
That familiarity can make it easier to reach out when a challenging case or clinical question arises. A discussion may also increase awareness of relevant clinical trials, specialist expertise, or other resources.
This can support physician-to-physician collaboration without turning every interaction into a formal referral.
It is also important to distinguish peer discussion from an oncology second opinion. A roundtable can provide another perspective, but participation does not automatically constitute a second opinion. A formal second opinion generally involves a defined clinical review by another physician or specialist.
The Role of Shared Care in Oncology Collaboration
Roundtables fit naturally within a broader shared care approach because both models emphasize communication between physicians.
The goal of shared care is not necessarily to move patients from a community practice to an academic center. Instead, physicians can collaborate when specialized expertise, treatment options, or clinical trial information may be relevant while maintaining continuity with the patient’s existing care team.
This is central to the 1104Health approach. Its Shared Care Network connects general oncologists, subspecialists, administrative care teams, and clinical investigators through structured opportunities for collaboration, including physician-led roundtables. The network is designed to support access to specialist expertise and clinical trial awareness while keeping referring physicians involved throughout the patient’s care journey.
1104Health’s physician roundtables bring local oncologists together with regional subspecialists to discuss treatments, complex cases, and evolving trial opportunities.
Building Stronger Connections Across Oncology Care
An oncology roundtable provides a setting for physicians to exchange knowledge, discuss clinical questions, and build connections across practice and institutional boundaries. It does not replace a formal tumor board, and it does not automatically serve as an oncology second opinion. Instead, it can complement existing clinical structures by creating another pathway for physician collaboration.
As cancer treatment becomes more specialized, community and academic physicians may benefit from opportunities to share expertise. Regional oncology collaboration can connect local physicians with broader expertise while supporting continuity.
Through its Shared Care Network, 1104Health supports this physician-first model by connecting oncologists with specialists, clinical investigators, and other oncology professionals. The aim is simply to make collaboration more accessible when physicians need additional perspectives, expertise, or trial information.
Frequently Asked Questions
1. What is an oncology roundtable?
An oncology roundtable is a physician-focused forum for discussing cancer cases, treatment developments, clinical questions, and emerging opportunities. The format varies by organization, but the emphasis is generally on peer learning and collaboration.
2. How is a roundtable different from a tumor board?
A tumor board is generally a structured multidisciplinary case-review process. A roundtable may be broader, with a focus on peer discussion, education, case exchange, and collaboration across practices or institutions. Some roundtables may include case review, so the distinction depends on how each meeting is organized.
3. Who attends an oncology roundtable?
Participants may include community oncologists, academic physicians, subspecialists, regional experts, and clinical investigators. The group can change depending on the disease area, cases, and purpose of the session.
4. How often are oncology roundtables held?
There is no single schedule that applies to all oncology roundtables. They may be held monthly, quarterly, or as part of a specific educational series. Frequency depends on the organization, region, specialty, and goals of the program.
5. Are roundtables useful for common cancer cases?
Yes. Both common and rare cases may be appropriate for discussion when physicians have questions about treatment approaches, new evidence, biomarkers, response, or clinical trials.
6. How do virtual and regional roundtables support collaboration?
They allow physicians from different locations to participate in structured discussions without needing to meet at one institution. Over time, these interactions may support regional oncology collaboration and stronger professional relationships.
